FCGR2A and macrophage activation syndrome: Based on the overexpression of FCGR genes in humans and the mouse model of MAS along with the identification of FGRP as a major pathway upregulated in patients during MAS, we propose that FCGR gene expression may be considered as a biomarker of MAS.